Clinical

Dataset Information

0

Trial of Second Generation Designer T Cells in Colorectal Carcinoma


ABSTRACT: The purpose of this study is to collect data on the safety and effectiveness of 2nd generation designer T cells in patients with colorectal cancer. Designer T cells are prepared by collecting white blood cells from the participant, and then modifying these cells in the laboratory so that they recognize the tumor antigen (CEA). These modified cells are then given back into the participant so that they can attack and kill tumor cells.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2055038 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2008-06-18 | E-GEOD-11386 | biostudies-arrayexpress
| PRJNA627400 | ENA
2005-12-15 | GSE3739 | GEO
2016-02-12 | E-GEOD-75488 | biostudies-arrayexpress
2008-06-05 | GSE11386 | GEO
2012-08-24 | E-GEOD-32363 | biostudies-arrayexpress
2010-06-10 | E-GEOD-8352 | biostudies-arrayexpress
2021-05-11 | GSE149109 | GEO
| PRJNA106505 | ENA
2023-06-21 | GSE202972 | GEO